Company profile: Continuus Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of Build-Own-Operate integrated continuous manufacturing solutions for small molecule pharmaceuticals, designing, building, and running client-site processes. Offerings include end-to-end ICM pilot plants, continuous reactive crystallization, solvent recovery systems, EMC for oral solid dosage forms, and automated modular assembly lines.
Products and services
- Integrated Continuous Manufacturing (ICM) Systems: Custom-engineered platform that continuously produces small‑molecule drugs by integrating various unit operations, streamlining the production process
- Automated Modular Assembly Line: Industrial-grade automated line that runs miniaturized, continuous production of pharmaceuticals, enhancing flexibility and efficiency for adaptable manufacturing
- End-to-End ICM Pilot Plant: Pilot-scale facility architected to demonstrate end‑to‑end continuous manufacturing of pharmaceuticals, validating feasibility and advantages of the ICM technology
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Continuus Pharmaceuticals
TMC Pharma Services
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical and biotech drug development support, offering clinical and nonclinical services, medical support and pharmacovigilance. Capabilities include regulatory strategy and submissions (pre- and post-approval), GxP quality assurance audits and consultancy, medical writing, orphan drug designation applications, paediatric investigation plans, and clinical trial applications with pre-clinical data review/validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TMC Pharma Services company profile →
ClinEdge
HQ: United States
Website
- Description: Provider of a full suite of clinical and trial management solutions to clinical research institutions, pharmaceutical companies, and CROs, providing business development and patient recruitment services and facilitating every stage of the clinical trial process, from site selection to staff support to patient engagement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinEdge company profile →
Cello Health
HQ: United States
Website
- Description: Provider of cutting-edge professional medical and marketing services to global pharmaceutical, biotechnology and health sectors, delivering a fusion of expertise through three distinct capabilities to unlock the potential of organisations, brands and assets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cello Health company profile →
Societal CDMO
HQ: United States
Website
- Description: Provider of contract development and manufacturing services focused on small molecule therapies, including drug product formulation development; clinical and commercial manufacturing of solid and liquid products (including controlled substances and high-potency molecules); analytical development and QC testing; clinical trial packaging and labeling; and regulatory consulting and FDA submission support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Societal CDMO company profile →
Financière de Tubize
HQ: Belgium
Website
- Description: Provider of investment holding focused on the biopharmaceutical industry, operating worldwide through its interest in UCB.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Financière de Tubize company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Continuus Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Continuus Pharmaceuticals
2.2 - Growth funds investing in similar companies to Continuus Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Continuus Pharmaceuticals
4.2 - Public trading comparable groups for Continuus Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →